, Tracking Stock Market Picks
Enter Symbol:
Resmed Inc. (RMD) [hlAlert]

Above Average
up 102.50 %

Resmed Inc. (RMD) rated Above Average with price target $72 by Caris & Company

Posted on: Thursday,  Apr 8, 2010  9:25 AM ET by Caris & Company

Caris & Company rated Above Average Resmed Inc. (NYSE: RMD) on 04/08/2010. Previously Caris & Company rated Above Average Resmed Inc. (NYSE: RMD)
on 01/02/2008., when the stock price was $25.51. Since then, Resmed Inc. has gained 102.51% as of 01/22/2016's recent price of $51.65.
If you would have followed the previous Caris & Company's recommendation on RMD, you would have gained 102.5% of your investment in 2942 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/8/2010 9:25 AM Buy
31.25 36.00
as of 12/31/2010
1 Week down  -10.11 %
1 Month up  0.15 %
3 Months down  -2.46 %
1 YTD up  22.44 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/8/2008 8:25 AM Buy
21.68 26.50
1/2/2008 10:42 AM Buy
25.51 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy